Since the COVID 19 Pandemic began, there has been a spirited debate over patent rights, including a highly publicized 20 month debate over a proposed WTO waiver on intellectual property rights. During that time a handful of countries have taken… Continue Reading →
On Friday, 15 July 2022 Knowledge Ecology International delivered the following opening statement at the 2022 WIPO General Assembly. The COVID pandemic illustrates flaws in the intellectual property system. In a public health crisis, no company should have a monopoly… Continue Reading →
Updated Friday, 17 June 2022, 11:30 AM Geneva time. Early Friday morning, 17 June 2022, the WTO’s 12th Ministerial Conference (chaired by Timur Suleymenov, Kazakshstan), adopted a Ministerial Decision on the TRIPS Agreement (WT/MIN(22)/W/15/Rev.2). The text can be found here.… Continue Reading →
Giulia Pamfili is a researcher at KEI. Giulia holds an MSc in Industrial Pharmacy (PharmD/CTF) from the University of Trieste and is a qualified Pharmacist in Italy. She is currently attending a Master program in Global Health with the University… Continue Reading →
28 questions for broadcast treaty May 12, 2022 Term of protection 1. The 1971 Convention for the Protection of Producers of Phonograms Against Unauthorized Duplication of Their Phonograms and The 1974 Brussels Convention Relating to the Distribution of Programme-Carrying Signals… Continue Reading →
ACTIV Partnership Records Records received via the KEI-NIH Freedom of Information Act (FOIA) lawsuit regarding an April 17, 2020 FOIA request for records relating to the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership, the private-public partnership announced by the… Continue Reading →
(More on this topic here: https://www.keionline.org/xtandi2021) On February 24, 2022, Senators Thom Tillis and Marsha Blackburn sent a letter to HHS Secretary Xavier Becerra (PDF copy). The letter refers to “petitions to march-in on a pharmaceutical product purely based on… Continue Reading →
The World Intellectual Property Organization’s (WIPO) 42nd session of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge, and Folklore (IGC) meets from 28 February 2022 to 4 March 2022. The focus of WIPO’s work this week is to finalize an… Continue Reading →
This is a letter from the three prostate cancer patient petitioners to HHS Secretary Becerra and Acting NIH Director Tabak, regarding the February 9, 2020 statement by Astellas on the Bayh-Dole march in and government rights case. The patient’s letter… Continue Reading →
(More on the Xtandi case here: https://www.keionline.org/xtandi2021) Astellas has issued a statement, dated February 9, 2022, on the Bayh-Dole Act and the petition to exercise march-in and government use rights in the prostate cancer drug Xtandi. It was brought to… Continue Reading →